Literature DB >> 14648659

Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.

J L Jones1, J A Shaw, J H Pringle, R A Walker.   

Abstract

In normal breast and ductal carcinoma in situ, myoepithelial cells form an incomplete layer separating the epithelial compartment from the stromal environment. Transition to invasive disease is marked by penetration of the myoepithelial-basement membrane (BM) interface. One mechanism involved in tumour invasion is breakdown of extracellular matrices by matrix metalloproteinases (MMPs). It was hypothesized that myoepithelial cells may modulate tumour invasion by controlling MMP gene expression, both in tumour cells and in peri-ductal fibroblasts. To investigate this, myoepithelial cells from normal breast were purified and characterized and their effect on tumour cell invasive potential was assessed. The effect on MMP gene expression of breast cancer cells cultured alone or in combination with primary normal breast fibroblasts was also analysed using RT-PCR with ELISA quantitation, with zymographic analysis to measure enzyme activity. Normal breast myoepithelial cells significantly reduced invasion by the breast cancer cell lines MCF-7, T47D, MDA-MB 231, and MDA-MB 468 when they were cultured alone or in the presence of a fibroblast population. Reduced invasion was associated with changes in MMP gene expression. In those tumour cells expressing MMP, there was a significant down-regulation of MMP-2 (MDA-MB 468, p<0.001), MMP-9 (MDA-MB 231, p=0.05; MDA-MB 468, p<0.001), and MT1-MMP (p<0.001 for both MDA-MB 231 and MDA-MB 468). Myoepithelial cells also caused a significant decrease in MMP gene expression in co-cultured fibroblasts. Furthermore, this was associated with reduced gelatinolytic activity as identified by zymography. This study demonstrates for the first time that primary myoepithelial cells from normal breast reduce breast cancer cell invasion and that this is mediated via modulation of both tumour cell and fibroblast function. This emphasizes the importance of the myoepithelial cell in controlling the breast microenvironment and focuses on the potential significance of the loss of this population with disease progression. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648659     DOI: 10.1002/path.1483

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  37 in total

1.  Progression of Ductal Carcinoma in Situ from the Pathological Perspective.

Authors:  Pedro Oscar R Cunha; Mark Ornstein; J Louise Jones
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

Review 2.  Myoepithelial cells: pathology, cell separation and markers of myoepithelial differentiation.

Authors:  Catherine Clarke; Jennifer Sandle; Sunil R Lakhani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.673

3.  CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression.

Authors:  Jeanne M V Louderbough; Jessie A Brown; Ray B Nagle; Joyce A Schroeder
Journal:  Genes Cancer       Date:  2011-08

4.  Cellular senescence and autophagy of myoepithelial cells are involved in the progression of in situ areas of carcinoma ex-pleomorphic adenoma to invasive carcinoma. An in vitro model.

Authors:  Carolina Amália Barcellos Silva; Elizabeth Ferreira Martinez; Ana Paula Dias Demasi; Albina Altemani; Jeruza Pinheiro da Silveira Bossonaro; Ney Soares Araújo; Vera Cavalcanti de Araújo
Journal:  J Cell Commun Signal       Date:  2015-04-21       Impact factor: 5.782

Review 5.  A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression.

Authors:  Edna Cukierman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

6.  Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model.

Authors:  Shawn P Carey; Alina Starchenko; Alexandra L McGregor; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2013-01-18       Impact factor: 5.150

7.  Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).

Authors:  Jérôme Toussaint; Virginie Durbecq; Sevilay Altintas; Valérie Doriath; Ghizlane Rouas; Marianne Paesmans; Philippe Bedard; Benjamin Haibe-Kains; Wiebren A Tjalma; Denis Larsimont; Martine Piccart; Christos Sotiriou
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

8.  Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.

Authors:  David S Guttery; Rachael A Hancox; Kellie T Mulligan; Simon Hughes; Sinead M Lambe; J Howard Pringle; Rosemary A Walker; J Louise Jones; Jacqueline A Shaw
Journal:  Breast Cancer Res       Date:  2010-08-02       Impact factor: 6.466

9.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

10.  Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.

Authors:  Siew-Kian Tai; Owen June-Keong Tan; Vincent Tak-Kwong Chow; Rongxian Jin; J Louise Jones; Puay-Hoon Tan; Anita Jayasurya; Boon-Huat Bay
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.